suprefact 100 nasal spray
sanofi-aventis new zealand limited - buserelin acetate 1 mg/ml - nasal spray solution - 1 mg/ml - active: buserelin acetate 1 mg/ml
suprefact depot 6.3 mg implant
sanofi-aventis ireland limited - buserelin - implant - 6.3 milligram
suprefact depot 2 months
sanofi - aventis israel ltd - buserelin acetate 6.6 mg - rods for implant - buserelin - treatment of advanced hormone - dependent prostatic carcinoma.
suprefact nasal spray
sanofi - aventis israel ltd - buserelin as acetate 0.1 mg/actuations - solution - buserelin - treatment of advanced hormone dependent prostatic carcinoma. endometriosis. use in ivf. precocious puberty. leyomyoma uteri.
suprefact nasal spray 0.1 mg
yousif mahmood hussain pharmacy - buserelin acetate - nasal spray - 0.1
suprefact injection
yousif mahmood hussain pharmacy - buserelin - injection
porceptal 4.2 mcg/ml solution for injection (im/iv)
msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - buserelin (vet.) - solution for injection (im/iv) - 4.2 mcg/ml
receptal solution for injection
intervet international b.v, netherlands - buserelin acetate - solution for injection - 4.2 u/ml
veterelin 0.004mg/ml solution for injection
vet specialists inc.; distributor: vet specialists inc. - buserelin (as acetate) - solution for injection - 0.004mg/ml
suprefact sol for inj. 1.05 mg/ml;
شركة ألفه للأدوية - ulfa pharma co. - buserelin acetate 1.05 mg/ml; - 1.05 mg/ml;